Cite

HARVARD Citation

    Torabi, J. et al. (2021). Commercial insurance delays direct‐acting antiviral treatment for hepatitis C kidney transplantation into uninfected recipients. Transplant infectious disease. 23 (1), p. n/a. [Online]. 
  
Back to record